Clinical trials
Pneumonia clinical trials
Below are recruiting pneumonia clinical trials, each written for real people, not researchers. We’re tracking 244 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07414693RecruitingPhase 4
Vitamin C for kids with severe pneumonia
This trial tests if giving vitamin C to children hospitalized with severe pneumonia can help them get better faster and leave the hospital sooner. It may be an option for children who have had pneumonia symptoms for 48 hours or less.
Multan Khurd, Punjab ProvinceAges 2 months–4.9 years - NCT07409727RecruitingPhase 4
Acetylcysteine inhalation to prevent pneumonia in ventilated patients
This trial tests if breathing in a medication called acetylcysteine can help prevent lung infections in patients who are on a breathing machine. If you or a loved one is on a ventilator, this treatment might reduce the chance of getting ventilator-associated pneumonia.
CairoAges 18–64 - NCT07403474RecruitingPhase 4
Using rapid testing to guide antibiotic choice in ventilator pneumonia
This trial tests whether using a rapid test to find the exact bacteria causing your pneumonia can help doctors choose the right antibiotics faster, which might improve your recovery. The study compares this approach to usual care in patients on ventilators.
AlèsAges 18 years+ - NCT07388680RecruitingPhase 2/Phase 3
Pirfenidone for radiation lung injury with or without immune pneumonia
This trial tests if pirfenidone capsules can help treat lung damage caused by radiation therapy, with or without immune-related pneumonia. It may be suitable for people with mild to moderate lung function impairment who have recently developed radiation lung injury.
Hefei, AnhuiAges 18–75 - NCT07358910Recruiting
Tracking infectious diseases in communities
This study looks at how infections spread in villages in Cambodia. If you live in a participating village, you might help us understand and prevent disease outbreaks.
Phnom Penh, Phnom PenhAges 2–75 - NCT07327619RecruitingPhase 3
Testing a New Antibiotic Combo for Hospital-Acquired Pneumonia
This trial tests a combination of two antibiotics (meropenem and pralurbactam) to see if they work better than other treatments for people with pneumonia that started in the hospital or from a breathing machine. If you qualify, this study might offer you a new treatment option.
Huaihua, HunanAges 18–80 - NCT07311343RecruitingPhase 4
Mouth care and antibiotics to prevent pneumonia after brain bleed
This trial tests whether a special mouth rinse and preventive antibiotics can lower the risk of pneumonia after a brain bleed (intracerebral hemorrhage). If you've had a small bleed in the upper part of the brain and are at risk for pneumonia, this study may help.
Beijing, Beijing MunicipalityAges 18–80 - NCT07298889Recruiting
Higher pressure support for pneumonia or ARDS patients
This trial tests whether using a higher level of pressure support (called PEEP) during noninvasive mask breathing can help people with pneumonia or ARDS (a serious lung condition) recover. It might be a good option if you need help breathing with a mask and meet the oxygen level requirements.
ChongqingAges 18 years+ - NCT05903352RecruitingPhase 3
Personalized antibiotic duration for hospital pneumonia patients
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
GarchesAges 18 years+ - NCT06890676Recruiting
Dental care in nursing homes to prevent infections and improve health
This study tests whether bringing dental care to nursing home residents can reduce mouth infections, pneumonia, and help control blood sugar in people with diabetes. If you live in a nursing home and are 60 or older, you may be able to join.
Jefferson City, MissouriAges 60–100 - NCT07268560Recruiting
Testing a new antibiotic combination for certain drug-resistant infections
This trial is checking how well a combination of two antibiotics, aztreonam and avibactam, works in patients who have a specific type of drug-resistant bacterial infection in the belly or lungs. It aims to offer a new treatment option for infections that are hard to cure.
Nanchang, JiangxiAges 18 years+ - NCT07245888Recruiting
Studying pneumonia in ventilated ICU patients
This study looks at different types of lung infections in ICU patients on breathing machines. By analyzing fluid from your lungs, researchers hope to better understand pneumonia and improve treatment.
LimogesAges 18 years+ - NCT05835479RecruitingPhase 2
Rezafungin to treat Pneumocystis pneumonia in adults with HIV
This Phase 2 trial tests rezafungin, an antifungal medicine, to treat Pneumocystis pneumonia (PCP) in adults living with HIV. It may help people recover faster or more effectively from this serious lung infection.
Cape TownAges 18 years+ - NCT06808074RecruitingPhase 4
Inhaled amikacin to prevent pneumonia in cirrhosis patients on ventilators
This trial tests whether inhaling an antibiotic called amikacin can prevent ventilator-associated pneumonia in patients with severe liver disease (cirrhosis) who are on a breathing machine. If you or your loved one is in the ICU with liver issues and needs a ventilator, this study may help reduce the risk of a serious lung infection.
Hyderabad, TelanganaAges 18 years+ - NCT07206745Recruiting
Chinese and Western medicine for severe pneumonia from drug-resistant bacteria
This trial tests a combination of traditional Chinese and Western medicine for adults with severe pneumonia caused by bacteria that are resistant to multiple antibiotics. It aims to see if this combined approach can improve treatment outcomes.
Zhengzhou, HenanAges 18–80 - NCT07203638Enrolling by invitation
Antibiotics to prevent pneumonia in ventilated patients
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
Banhā, Al-QalyubiaAges 18–70 - NCT07181200Recruiting
Pneumonia test study for children 12-24 months old
This study looks at a urine test for pneumonia in children aged 12 to 24 months. It aims to see if the test can help diagnose pneumonia better, especially in those with symptoms like fever, cough, and fast breathing.
BlantyreAges 1–2 - NCT06949904RecruitingPhase 1/Phase 2
Melatonin as an add-on therapy for childhood pneumonia
This trial tests whether adding melatonin to standard pneumonia treatment helps children recover faster. It is for children aged 1 month to 12 years with pneumonia or severe pneumonia.
Islamabad, IslamabadAges 1 month–12 years - NCT07164131RecruitingPhase 4
Comparing two antibiotics for hospitalized pneumonia patients
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
Scottsdale, ArizonaAges 18 years+ - NCT07113951Enrolling by invitation
AI-ROSE for diagnosing severe pneumonia
This trial uses an AI tool called AI-ROSE to analyze lung fluid from a bronchoscopy. It aims to help doctors quickly diagnose severe pneumonia and guide treatment.
Nanjing, JiangsuAges 18 years+ - NCT03031210RecruitingPhase 2/Phase 3
Twice-daily amoxicillin for mild childhood pneumonia
This trial tests whether twice-daily amoxicillin helps treat non-severe pneumonia in children. It may be a good option if your child has a mild form confirmed by symptoms and a chest X-ray.
Montreal, QuebecAges 3 months–18 years - NCT07089186RecruitingPhase 3
Study of meropenem and pralurbactam for certain antibiotic-resistant infections
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
ShanghaiAges 18–80 - NCT07086391Recruiting
Inhaled Polymyxin B for Resistant Pneumonia
This trial tests different ways of giving an inhaled antibiotic (polymyxin B) to people on a ventilator who have pneumonia caused by tough bacteria that don't respond to usual antibiotics. The goal is to find the best way to deliver the medicine to help clear the infection.
Fuzhou, FujianAges 18–90 - NCT06972537Recruiting
Piperacillin-Tazobactam Dosing for Pneumonia in Older Adults
This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.
Jinan, ShandongAges 65–100
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pneumonia?
- Yes. Clin2 currently lists 244 recruiting pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.